This article is more than 5 years old. Information may no longer be current.
New treatment for hyperopic presbyopes safe, effective, study shows
BOSTON — A laser procedure undergoing clinical trials for treating hyperopia has been shown to be "noninvasive, simple, rapid, comfortable and repeatable," according to researchers here at Academy 2011 Boston.
In the prospective, single arm, nonrandomized clinical study, 10 patients older than 40 and with hyperopia were treated with NTK optimal keratoplasty (Opti-K) in their dominant eye, reported Sherry Audycki, OD, BS, and colleagues, and the other eye was used as the control. Five eyes received a secondary treatment, and safety and efficacy were measured 6 months after the second treatment.
According to the study abstract, the change in endothelial cell count was no different in the treated and control eyes, and no adverse effects were seen.
All patients achieved 20/40 or better visual acuity at 3 months, and the patients that received two treatments within the 1 month protocol achieved 20/25 at 6 months. One eye regressed to pretreatment status, the researchers reported.
They concluded that "Opti-K appears to be safe and effective for the treatment of mild hyperopic presbyopic patients."
- Disclosures: Dr. Audycki and colleagues have no relevant financial disclosures.